(Reuters)—The U.S. Drug Enforcement Administration (DEA) on Friday proposed a 20% reduction in the manufacture of certain commonly prescribed opioid painkillers, as well as other controlled substances for next year. The proposal comes as U.S. regulators and lawmakers take steps to limit the supply of opioids—a class of drugs that include prescription painkillers and heroin—to…
Search results for: Opana ER
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Information on New Drug Approvals and Medication Safety
Rheumatology-related drug safety, approvals, and what’s in the pipeline.
Drug UPDATES
Information on New Approvals and Medication Safety
The Saddest Disease to Prevent
When preventing a disease is harder than its treatment
Drug Updates
Information on New Approvals and Medication Safety